Europe PMC
Cure8 research brief
Why This Matters
The study suggests most adults with chronic diarrhea in this tertiary setting had organic/inflammatory disease and identifies accessible clinical and lab predictors that could help prioritize endoscopic evaluation.
Who Should Pay Attention
Adult patients with chronic diarrhea, gastroenterology clinicians, and researchers interested in diagnostic predictors for organic GI disease.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This analysis suggests that in a tertiary-care outpatient population in Damascus, organic gastrointestinal disease is the leading cause of chronic diarrhea and that simple clinical features (nocturnal symptoms, blood/mucus) and routine lab tests (CRP, hemoglobin) may help select patients for prompt endoscopic evaluation.
The study is retrospective and based on chart review from one center between 2023–2026, so findings reflect that hospital’s referred population and may over-represent inflammatory and organic diagnoses compared with primary-care settings.
If you have chronic diarrhea, these findings support discussing alarm features (night-time symptoms, visible blood/mucus, unexplained anemia) with your clinician to determine whether endoscopic testing is appropriate.
Keep In Mind
This is a single-center, retrospective study (preprint/abstract-level content). Results may not generalize to community or primary-care populations because tertiary centers often see more complex cases. The source content is an abstract-level report rather than a full peer-reviewed article.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationEurope PMC
AuthorsAlfawares MA, Mansour MA, Ali AF
Study typePreprint
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 10, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Association of serological markers with endoscopic mucosal healing and disease activity in patients with inflammatory bowel disease: a retrospective study
Blood markers that correlate with endoscopic healing could help track inflammation noninvasively and may reduce the frequency of endoscopy if validated. For people with IBD, better blood-based tools could make monitoring...
Evaluation of serum human galectin 3 as a marker of activity in inflammatory bowel disease in comparison to fecal calprotectin.
Noninvasive blood biomarkers that track IBD activity could reduce reliance on repeat endoscopy. If validated, serum galectin‑3 might complement fecal calprotectin and CRP to help identify active disease.
The Diagnostic Accuracy of Fecal Calprotectin for Colonoscopic Abnormalities in Patients With Chronic Diarrhea.
Fecal calprotectin measured by a point‑of‑care CGICA assay showed high accuracy for identifying colorectal inflammation and IBD in patients with chronic diarrhea, which could help avoid some unnecessary colonoscopies...